InvestorLens

FDMT — 4D MOLECULAR THERAPEUTICS IN

Public company

Sign in to save3 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About 4D MOLECULAR THERAPEUTICS IN (FDMT)

4D MOLECULAR THERAPEUTICS IN (FDMT) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $12M. Across recent filings, tracked investors recorded 3 new positions, 2 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in FDMT

100
/100
Strong Institutional Accumulation
Added / Increased5
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track FDMT

20
/100
Emerging Interest
3investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

FDMT Ownership Composition

How 4D MOLECULAR THERAPEUTICS IN is held across tracked investor types, based on reported 13F positions.

Dominant Type
Hedge Funds
76% of tracked value
Institutions
3
tracked investors
Total Reported
$15.2M
combined 13F value
Sectors2
  • Hedge Funds75.9%
  • Other24.1%
Hedge Funds(1)
75.9%
Other(2)
24.1%

Tracked investors reporting FDMT

  • Steve CohenDec 31, 2025
    Point72 Asset Management
    Shares
    1.5M
    Value
    $11.5M
    % Portfolio
    0.01%
  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    317.1K
    Value
    $3M
    % Portfolio
    0.00%
  • Izzy EnglanderDec 31, 2025
    Millennium Management
    Shares
    96.4K
    Value
    $722.7K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold FDMT?
3 tracked institutional investors disclosed a position in FDMT (4D MOLECULAR THERAPEUTICS IN) in their most recent 13F filing.
Who is the largest institutional holder of FDMT?
Steve Cohen, Point72 Asset Management, holds the largest disclosed position in FDMT, valued at $12M.
Did institutional ownership of FDMT increase or decrease?
Across recent 13F filings, tracked investors recorded 3 new positions, 2 increased, 0 reduced, and 0 fully exited FDMT.
Where does this FDMT ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
FDMT (4D MOLECULAR THERAPEUTICS IN) — Institutional Holders — InvestorLens